Cite
APA Citation
Arkenau, H., Martin‐Liberal, J., Calvo, E., Penel, N., Krebs, M. G., Herbst, R. S., Walgren, R. A., Widau, R. C., Mi, G., Jin, J., Ferry, D., & Chau, I. (2018). ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF). Oncologist, 23, 1407–e136. http://access.bl.uk/ark:/81055/vdc_100076295739.0x000024